MD, PhD, FRCPC
Our lab is interested in developing new therapeutic strategies for AML (acute myeloid leukemia) that effectively target leukemic stem cells. Using genetic and chemical approaches, including high throughput screens, we identify biological vulnerabilities in the AML cells and stem cells with a focus on mitochondrial and metabolic pathways. Through these efforts, we discover new biological pathways important for the growth and viability of AML and highlight new therapeutic approaches for this disease.
Princess Margaret Cancer Centre
"Experiential learning helps to shape the direction of your projects. It’s not just keeping us engaged as students but shaping the path of what we’re doing.”
- Katie Tucker, Cohort 2017